Diabetic Transplantations

Type 1 diabetes results from the destruction of insulin-producing cells in the islets of the pancreas. Islet cell transplantation involves extracting islet cells from the pancreas of a deceased donor and implanting them in the liver of someone with Type 1. This minor procedure is usually done twice for each transplant patient, and can be performed with minimal risk using a needle under local anaesthetic. Islet transplants have been shown to reduce the risk of severe hypos. Results from UK islet transplant patients showed that the frequency of hypos was reduced from 23 per person per year before transplantation to less than one hypo per person per year afterwards.

Islet transplants usually also lead to improved awareness of hypoglycaemia, less variability in blood glucose levels, improved average blood glucose, improved quality of life and reduced fear of hypos. Long-term results are good and are improving all the time. For example, the majority of transplant patients can now expect to have a functioning transplant after six years and some people have had more than 10 years of clinical benefit.

Post-transplantation diabetes mellitus (PTDM), also known as new-onset diabetes mellitus (NODM), occurs in 10–15% of renal transplant recipients and is associated with cardiovascular disease and reduced lifespan. In the majority of cases, PTDM is characterized by β-cell dysfunction, as well as reduced insulin sensitivity in liver, muscle and adipose tissue. Glucose-lowering therapy must be compatible with immunosuppressant agents, reduced glomerular filtration rate (GFR) and severe arteriosclerosis. Such therapy should not place the patient at risk by inducing hypoglycaemic episodes or exacerbating renal function owing to adverse gastrointestinal effects with hypovolaemia.

  • Xenotransplantation for the Treatment of Type 1 Diabetes
  • Beta Cell Regeneration
  • Clinical Trial on Islet Transplants
  • Islet Cell Transplantation for Diabetes
  • Pancreas Transplantation
  • Kidney Transplants

Related Conference of Diabetic Transplantations

March 27-28, 2023

56th Annual Congress on Endocrinology & Disorders

Vancouver, Canada
April 18-19, 2023

Global Summit on Endocrinology

Madrid, Spain
April 18-19, 2023

European Endocrinology and Diabetes Congress

Madrid, Spain
April 20-21, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain
June 05-06, 2023

World Congress on Endocrine and Diabetes

San Francisco, USA
June 15-16, 2023

4th Annual conference on Diabetes

San Francisco, USA
July 24-25, 2023

18th International Summit on Diabetes

Venice, Italy
August 10-11, 2023

25th World Congress on Diabetes and Endocrine Disorders

Dublin, Ireland
September 07-08, 2023

19th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
September 12-13, 2023

7th Annual Conference on Diabetes and Endocrinology

Barcelona, Spain
September 14-15, 2023

3rd Annual Summit on Diabetes and Endocrinology

Bangkok, Thailand
October 16-17, 2023

2nd World congress and Expo on Diabetes

Vancouver, Canada
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA
November 20-21, 2023

17th European Diabetes and Endocrinology Congress

Dubai, UAE
November 27-28, 2023

27th International Conference on Diabetes, Endocrinology and Healthcare

Singapore City, Singapore

Diabetic Transplantations Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in